Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study.
Cobbold JFL, Atkinson S, Marchesi JR, Smith A, Wai SN, Stove J, Shojaee-Moradie F, Jackson N, Umpleby AM, Fitzpatrick J, Thomas EL, Bell JD, Holmes E, Taylor-Robinson SD, Goldin RD, Yee MS, Anstee QM, Thursz MR.
Cobbold JFL, et al. Among authors: marchesi jr.
Hepatol Res. 2018 Jan;48(1):69-77. doi: 10.1111/hepr.12904. Epub 2017 May 31.
Hepatol Res. 2018.
PMID: 28425154
Free article.